Purified anti-mouse/human CD45R/B220 Antibody

Pricing & Availability
Clone
RA3-6B2 (See other available formats)
Regulatory Status
RUO
Other Names
B220
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1_RA3-6B2_Pure_112911
C57BL/6 mouse slenocytes were stained with purified B220 (clone RA3-6B2) (filled histogram) or rat IgG2a, κ (open histogram), followed by anti-rat IgG FITC.
  • 1_RA3-6B2_Pure_112911
    C57BL/6 mouse slenocytes were stained with purified B220 (clone RA3-6B2) (filled histogram) or rat IgG2a, κ (open histogram), followed by anti-rat IgG FITC.
  • 2_RA3-6B2_PURE_CD45R_IHC-F_091018
    C57BL/6 mouse frozen spleen section was fixed with 4% paraformaldehyde (PFA) for ten minutes at room temperature and blocked with 5% FBS for 30 minutes at room temperature. Then, the section was stained with 10 µg/mL of purified anti-mouse/human CD45R/B220 (clone RA3-6B2) and anti-mouse CD3ε (clone 500A2) Alexa Fluor® 594 (red) overnight at 4°C, followed by 2.5 µg/mL of anti-rat IgG (clone Poly4054) Alexa Fluor® 488 (green) for two hours at room temperature. Nuclei were counterstained with DAPI (blue). The image was captured by 10X objective.
  • RA3-6B2_PURE_CD45R_IHC-F_102418
    Fresh, frozen mouse spleen was stained with purified CD45R/B220 clone Ra3-6B2 conjugated and detected with a FITC CODEX™ oligonucleotide duplex (red). Samples were counterstained with TCT A647 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Cat # Size Price Quantity Avail. Save
103201 50 µg 20,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103202 500 µg 60,00€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse, Human, Cross-Reactivity: Cat (Feline)
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF®, IHC-F - Verified
IHC-P, IP, Activ - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. For immunohistochemistry on frozen tissue sections, a concentration range of 5.0 - 10 µg/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, and immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
Product Citations
  1. Nagashima K, et al. 2017. Biochem Biophys Res Commun. . 10.1016/j.bbrc.2017.09.004. PubMed
  2. Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
  3. Gröschel C, et al. 2017. Sci Rep.. 10.1038/s41598-017-16147-1. PubMed
  4. Quaranta V, et al. 2018. Cancer Res. 2018:5379085. PubMed
  5. Grohmann M et al. 2018. Cell. 175(5):1289-1306 . PubMed
  6. De Schepper S et al. 2018. Cell. 175(2):400-415 . PubMed
  7. Nagatake T, et al. 2018. Int Immunol. 30:471. PubMed
  8. Adamson SE, et al. 2018. Arterioscler Thromb Vasc Biol. 38:1020. PubMed
  9. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  10. Dubey LK, et al. 2019. Cell Rep. 27:2442. PubMed
  11. Chung WY, et al. 2018. ALTEX. 36:29. PubMed
  12. Yin S et al. 2019. Cancer cell. 35(2):283-296 . PubMed
  13. Simmons S et al. 2019. Elife. 8 pii: e41239. PubMed
  14. Stacey MA, et al. 2017. J Clin Invest. 127:1463. PubMed
  15. Telford W, et al. 2017. Cytometry A. 91:314. PubMed
  16. Wang HC, et al. 2017. J Immunol. 198:3149. PubMed
  17. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  18. Schneppenheim J, et al. 2017. J Immunol. 199:172. PubMed
  19. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  20. Akiel M, et al. 2017. Cancer Res. 77:4014. PubMed
  21. Chiu H, et al. 2017. Front Immunol. 0.852083333. PubMed
  22. Kawabe T, et al. 2017. Sci Immunol. 2:eaam9315. PubMed
  23. Goel S, et al. 2017. Nature. 548:471. PubMed
  24. Wang W, et al. 2018. J Vasc Surg. 68:1538. PubMed
  25. Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
  26. Duncan CG, et al. 2018. G3 (Bethesda). 0.892361111. PubMed
  27. Chartrand K, et al. 2018. Front Immunol. 1.642361111. PubMed
  28. Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
  29. Sun H, et al. 2018. J Cell Biol. 217:1453. PubMed
  30. Fonseca JA, et al. 2018. Vaccine. 36:2799. PubMed
  31. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  32. Wan X, et al. 2018. Nature. 560:107. PubMed
  33. Ito Y, et al. 2018. J Exp Med. 215:2617. PubMed
  34. Zhao L, et al. 2018. Nat Med. 24:1536. PubMed
  35. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  36. Piliponsky AM, et al. 2019. Nat Immunol. 0.922916667. PubMed
  37. Chen S, et al. 2018. Immunohorizons. 0.345138889. PubMed
  38. Rosenbaum M, et al. 2019. Nat Commun. 2.05. PubMed
  39. Stebegg M, et al. 2019. Nat Commun. 2.113194444. PubMed
  40. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  41. Ng SR, et al. 2020. Proc Natl Acad Sci U S A. 117:513. PubMed
  42. Abboud G, et al. 2018. Front Immunol. 9:1973. PubMed
  43. Cole C, et al. 2018. Nucleic Acids Res. 46:e62. PubMed
  44. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  45. Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
  46. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  47. Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
  48. Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
  49. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  50. King IL, et al. 2017. Mucosal Immunol. 10:1160. PubMed
  51. Yoon BH, et al. 2018. Mol Cells. 41:953. PubMed
  52. Umemoto T, et al. 2017. EMBO J. 36:2390. PubMed
  53. Luo W, et al. 2019. Nat Immunol. 20:736. PubMed
  54. Mainini F, et al. 2018. Nucleic Acid Ther. 28:225. PubMed
  55. Shin J, et al. 2018. Diabetes. 67:1068. PubMed
  56. Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
  57. Chen L, et al. 2019. Nat Commun. 3.553472222. PubMed
  58. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  59. Lang G, et al. 2008. Blood. 111:2158. PubMed
  60. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  61. Lebert-Ghali C, et al. 2016. Blood. 127: 87-90. PubMed
  62. Alrefai H, et al. 2016. Nat Commun. 7:11724. PubMed
  63. Fujimura N, et al. 2016. J Vasc Surg. 64: 46-54. PubMed
  64. Dungubat E, et al. 2020. Nutrients. 12:00. PubMed
  65. Feng X, et al. 2020. DNA Repair (Amst). 86:102754. PubMed
  66. Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed
  67. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  68. Heib T, et al. 2021. Cell Reports. 35(6):109102. PubMed
RRID
AB_312986 (BioLegend Cat. No. 103201)
AB_312987 (BioLegend Cat. No. 103202)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 04.25.2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account